BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 33917086)

  • 21. Somatic alterations in the melanoma genome: a high-resolution array-based comparative genomic hybridization study.
    Gast A; Scherer D; Chen B; Bloethner S; Melchert S; Sucker A; Hemminki K; Schadendorf D; Kumar R
    Genes Chromosomes Cancer; 2010 Aug; 49(8):733-45. PubMed ID: 20544847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BRAF, KIT, and NRAS Mutations of Acral Melanoma in White Patients.
    Dika E; Veronesi G; Altimari A; Riefolo M; Ravaioli GM; Piraccini BM; Lambertini M; Campione E; Gruppioni E; Fiorentino M; Melotti B; Ferracin M; Patrizi A
    Am J Clin Pathol; 2020 Apr; 153(5):664-671. PubMed ID: 32017841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detecting copy number alterations of oncogenes in cell-free DNA to monitor treatment response in acral and mucosal melanoma.
    Mikoshiba A; Ashida A; Sakaizawa K; Kiniwa Y; Okuyama R
    J Dermatol Sci; 2020 Mar; 97(3):172-178. PubMed ID: 31987696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Marked genetic differences between BRAF and NRAS mutated primary melanomas as revealed by array comparative genomic hybridization.
    Lázár V; Ecsedi S; Vízkeleti L; Rákosy Z; Boross G; Szappanos B; Bégány A; Emri G; Adány R; Balázs M
    Melanoma Res; 2012 Jun; 22(3):202-14. PubMed ID: 22456166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Copy number changes of clinically actionable genes in melanoma, non-small cell lung cancer and colorectal cancer-A survey across 822 routine diagnostic cases.
    Pfarr N; Penzel R; Klauschen F; Heim D; Brandt R; Kazdal D; Jesinghaus M; Herpel E; Schirmacher P; Warth A; Weichert W; Endris V; Stenzinger A
    Genes Chromosomes Cancer; 2016 Nov; 55(11):821-33. PubMed ID: 27218826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of candidate gene copy number alterations in the 11q13 region along with BRAF and NRAS mutations in human melanoma.
    Lázár V; Ecsedi S; Szöllosi AG; Tóth R; Vízkeleti L; Rákosy Z; Bégány A; Adány R; Balázs M
    Mod Pathol; 2009 Oct; 22(10):1367-78. PubMed ID: 19633643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Telomerase Reverse Transcriptase Protein Expression Is More Frequent in Acral Lentiginous Melanoma Than in Other Types of Cutaneous Melanoma.
    Cho WC; Wang WL; Milton DR; Ingram DR; Nagarajan P; Curry JL; Ivan D; Lazar AJ; Hwu WJ; Prieto VG; Torres-Cabala CA; Aung PP
    Arch Pathol Lab Med; 2021 Jul; 145(7):842-850. PubMed ID: 33053175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrating Next-Generation Sequencing with Morphology Improves Prognostic and Biologic Classification of Spitz Neoplasms.
    Quan VL; Zhang B; Zhang Y; Mohan LS; Shi K; Wagner A; Kruse L; Taxter T; Beaubier N; White K; Zou L; Gerami P
    J Invest Dermatol; 2020 Aug; 140(8):1599-1608. PubMed ID: 32004563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genomic profiling of malignant melanoma using tiling-resolution arrayCGH.
    Jönsson G; Dahl C; Staaf J; Sandberg T; Bendahl PO; Ringnér M; Guldberg P; Borg A
    Oncogene; 2007 Jul; 26(32):4738-48. PubMed ID: 17260012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical, environmental and histological distribution of BRAF, NRAS and TERT promoter mutations among patients with cutaneous melanoma: a retrospective study of 563 patients.
    Manrique-Silva E; Rachakonda S; Millán-Esteban D; García-Casado Z; Requena C; Través V; Kumar R; Nagore E
    Br J Dermatol; 2021 Mar; 184(3):504-513. PubMed ID: 32506424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systematic review and meta-analysis of genomic alterations in acral melanoma.
    Broit N; Johansson PA; Rodgers CB; Walpole ST; Hayward NK; Pritchard AL
    Pigment Cell Melanoma Res; 2022 May; 35(3):369-386. PubMed ID: 35229492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of BRAF V600E mutation in Chinese melanoma patients: large scale analysis of BRAF and NRAS mutations in a 432-case cohort.
    Si L; Kong Y; Xu X; Flaherty KT; Sheng X; Cui C; Chi Z; Li S; Mao L; Guo J
    Eur J Cancer; 2012 Jan; 48(1):94-100. PubMed ID: 21788131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted next generation sequencing reveals unique mutation profile of primary melanocytic tumors of the central nervous system.
    van de Nes J; Gessi M; Sucker A; Möller I; Stiller M; Horn S; Scholz SL; Pischler C; Stadtler N; Schilling B; Zimmer L; Hillen U; Scolyer RA; Buckland ME; Lauriola L; Pietsch T; Waha A; Schadendorf D; Murali R; Griewank KG
    J Neurooncol; 2016 May; 127(3):435-44. PubMed ID: 26744134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular profiling, including TERT promoter mutations, of acral lentiginous melanomas.
    Vazquez Vde L; Vicente AL; Carloni A; Berardinelli G; Soares P; Scapulatempo C; Martinho O; Reis RM
    Melanoma Res; 2016 Apr; 26(2):93-9. PubMed ID: 26709572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Somatic activation of KIT in distinct subtypes of melanoma.
    Curtin JA; Busam K; Pinkel D; Bastian BC
    J Clin Oncol; 2006 Sep; 24(26):4340-6. PubMed ID: 16908931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acral melanoma foot lesions. Part 1: epidemiology, aetiology, and molecular pathology.
    Desai A; Ugorji R; Khachemoune A
    Clin Exp Dermatol; 2017 Dec; 42(8):845-848. PubMed ID: 28940724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Meta-Analysis and Systematic Review of the Genomics of Mucosal Melanoma.
    Broit N; Johansson PA; Rodgers CB; Walpole ST; Newell F; Hayward NK; Pritchard AL
    Mol Cancer Res; 2021 Jun; 19(6):991-1004. PubMed ID: 33707307
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Ponti G; Manfredini M; Greco S; Pellacani G; Depenni R; Tomasi A; Maccaferri M; Cascinu S
    Anticancer Res; 2017 Dec; 37(12):7043-7048. PubMed ID: 29187493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Telomerase reverse transcriptase (TERT) promoter mutations in Korean melanoma patients.
    Roh MR; Park KH; Chung KY; Shin SJ; Rha SY; Tsao H
    Am J Cancer Res; 2017; 7(1):134-138. PubMed ID: 28123854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and molecular features of subungual melanomas are site-specific and distinct from acral melanomas.
    Holman BN; Van Gulick RJ; Amato CM; MacBeth ML; Davies KD; Aisner DL; Robinson WA; Couts KL
    Melanoma Res; 2020 Dec; 30(6):562-573. PubMed ID: 33156595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.